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Abstract
The human b-globin locus contains the b-like globin genes (i.e. fetal c-globin and adult b-globin), which heterotetramerize
with a-globin subunits to form fetal or adult hemoglobin. Thalassemia is one of the commonest inherited disorders in the
world, which results in quantitative defects of the globins, based on a number of genome variations found in the globin
gene clusters. Hereditary persistence of fetal hemoglobin (HPFH) also caused by similar types of genomic alterations can
compensate for the loss of adult hemoglobin. Understanding the regulation of the human c-globin gene expression is a
challenge for the treatment of thalassemia. A mouse model that facilitates high-throughput assays would simplify such
studies. We have generated a transgenic dual reporter mouse model by tagging the c- and b-globin genes with GFP and
DsRed fluorescent proteins respectively in the endogenous human b-globin locus. Erythroid cell lines derived from this
mouse model were tested for their capacity to reactivate the c-globin gene. Here, we discuss the applications and
limitations of this fluorescent reporter model to study the genetic basis of red blood cell disorders and the potential use of
such model systems in high-throughput screens for hemoglobinopathies therapeutics.
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Introduction
The human b-globin locus spans ,70 Kb containing the
regulatory sequences of the Locus Control Region (LCR) and the
b-like globin genes situated in the same order as they are expressed
throughout ontogeny [59- HBE (e) - HBG2 (Gc) - HBG1 (Ac) -
HBD (d) - HBB (b) -39]. Mice carrying a ‘‘minilocus’’ transgene,
containing the essential distal regulatory elements surrounding the
HBB gene, express it at levels equivalent to the endogenous mouse
b-globin and have given valuable information related to regulatory
regions, position-independent and copy number-dependent ex-
pression [1]. Mice bearing the entire human b-globin locus have
been a useful model to understand developmental expression
patterns of the five functional human b-like globin genes [2].
Combined studies on human and mouse globins have revealed
common and different aspects of human and mouse erythropoi-
esis. While in human there are two globin switches (HBE to
HBG1/HBG2, occurring in the transition from primitive to
definitive erythropoiesis, and HBG1/HBG2 to HBB, occurring in
definitive erythropoiesis around the time of birth), there is only one
switch in mouse occurring at the time of transition between
primitive and definitive erythropoiesis [3]. Expression of the
murine bminor and bmajor genes starts in the primitive cells and
peaks at definitive stage when the embryonic e and bh1 are no
longer expressed [4]. Early studies on the human b-globin locus
transgenic mice demonstrated expression of c-globin in the
embryonic stage as well as in the early fetal liver of the mouse
whereas the b-globin gene was expressed in the fetal and adult
stages [2].
The transition from c- to b-globin during development involves
both genes in a competitive model of transcriptional regulation [5–
7]. A number of studies have confirmed the complexity of this
process and have pointed out the need of a flexible and reliable
model that facilitates high-throughput analyses. This has been
attempted by substituting the globin genes with fluorescent
proteins under the regulatory elements of the b-globin locus
[8,9]. However, due to the length of the complete human b-globin
locus, most of the reporter constructs used to date are partial
representations of the locus that can be easily manipulated and
introduced in erythroid cells by standard transfection techniques.
Missing genomic sequences may affect expression of the globin
genes, which may lead to unreliable results in terms of
physiological relevance. Therefore, such reporter assays should
ideally be performed in the context of the complete locus [10,11].
The generation of a reporter mouse model, where erythropoiesis
can be studied at the developmental level, under steady-state and
under stress conditions, would therefore be highly advantageous,
in particular since erythroid cell lines generated from these mice
could be used for high-throughput screening purposes.
Here we describe the generation of two lines of transgenic mice
carrying the full-length b-globin locus with dual fluorescent
reporter genes, HBG1-GFP|HBB-DsRed (cGFP/bDsRed) and
HBG1-GPA-GFP|HBB-DsRed (cGPA-GFP/bDsRed). These
lines differ in the cellular localization of the GFP reporter signal
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for c-globin, i.e. cytoplasmic or at the membrane surface
respectively. These mice allow in vivo tracing of HBG1 (c-globin)
gene expression during development by flow cytometry or
fluorescent microscopy. They can be used to test potential
treatment modalities aimed at reactivating the expression of c-
globin in the adult stage. Additionally, we have generated fetal
liver cell lines derived from these transgenic mice for in vitro
experiments, especially for functional screens with libraries of
chemical compounds, antibodies and shRNA clones, and molec-
ular studies that require large amounts of cells. In addition, the
limitations of this and other current reporter mouse models will be
discussed with the aim to shed light to the generation of future
globin reporter systems.
Materials and Methods
Ethics Statement
Animal housing, mouse strains (C57BL/6, FVB), knockout mice
(p53) and transgenesis procedures used for the purposes of this
study fall within the norms set by the ethics committee of Erasmus
Medical Center (Rotterdam, The Netherlands). The in vivo
experiment performed in this study and previously described by
Rupon et al [12] which includes intraperitoneal administration of
phenylhydrazine (PHZ) and azacytidine (AZA) was permitted
under the protocol (DEC Nr. EMC2103, 138-10-08).
The ethics committee of Erasmus Medical Center (Rotterdam,
The Netherlands) has approved all experimental protocols used to
complete this study.
Modification of the human b-globin locus in a PAC vector
and generation of transgenic mice
The HBG1 and HBB genes (PAC2 vector) were modified at the
first ATG of the transcript by introducing the EGFP-N2 (720 bp,
Clontech) or GPA-(EGFP-N2) and DsRed2 (700 bp, Clontech)
cDNA respectively followed by a stop codon. Mouse Glycophorin
A cDNA (GPA, 507 bp) was cloned and modified by introducing
the EGFP-N2 cDNA 114 bp downstream from the start site of
transcription by mutating a single base (Stratagene QuikChange II
Site-Directed Mutagenesis Kit, Agilent Technologies) thus creat-
ing a BamHI site. The modified globin genes were used to
subsequently replace the endogenous genes in the PAC2 vector by
homologous recombination [13].
Fertilized oocytes from C57BL/6 mice were injected with SceI
linearized modified b-globin locus devoid of vector sequences and
three transgenic lines were generated, two of them from the
EGFP-N2 and one from the GPA-(EGFP-N2) construct.
Southern Blotting, S1 nuclease protection assays and
qPCR
Southern blotting was performed for mapping the modified b-
globin locus after each recombination step to ensure integrity of
the construct. DNA was digested with different restriction enzymes
and run on 0.6% agarose gel. The membrane was hybridized at
65uC with the two cosmid probes, cosLCR-e and cosccdb [2]
spanning the human b-globin locus.
S1 RNA analysis of murine globin expression was performed as
described previously [2].
RNA from fetal liver cells was isolated using Trizma reagent
(Sigma). cDNA was synthesized with SuperScript-II kit (SS-II,
Invitrogen). Real Time quantitative PCR analysis was performed
on an iCycler (BioRad) or Opticon I (MJ Research) system
monitor using SYBR Green I. Enrichment for a specific sequence
was calculated as 2 to the power of (2DCT), using Hypoxanthine-
guanine phosphoribosyltransferase (Hprt1) and Glyceraldehyde-3-
phosphate dehydrogenase (Gapdh) as housekeeping reference
transcripts.
Primers used:
GFP: 59-gacgacggcaactacaagac-39 and 59-cgttgtggctgttgtagttgt-
39.
DsRed: 59-aagggcgagacccacaag-39 and 59-gtgtagtcctcgttgtggga-
39.
Hprt1: 59-agcctaagatgagcgcaagt-39 and 59-atggccacaggacta-
gaaca-39.
Gapdh: 59-cctgccaagtatgatgacat-39 and 59-gtcctcagtgtagcccaag-
39.
Flow cytometry analysis
Analysis of embryonic or adult blood and primary fetal liver
cells or cell lines was performed with either a FACSAria or a
FACScan (Becton Dickinson, BD). Cells were resuspended in 1%
BSA/PBS. Hoechst or 7-AAD (Molecular Probes) were used to
stain dead cells. Antibodies for CD71-PECy7 and CD117-
APCCy7 were purchased from BD Biosciences. Analysis of the
data obtained was performed with FlowJo software (Tree Star Inc).
Culture of primary fetal liver cells and generation of
transgenic cell lines
Fetal liver cells were cultured in Stem Pro media (Invitrogen) in
the presence of erythropoietin (Epo, 1 U/ml), stem cell factor
(SCF, 100 ng/ml) and dexamethasone (Dex, 1026 M; Sigma). All
transgenic mice were bred with p53 knockout mice [14] to
homozygosity to generate fetal liver cell lines as described [15,16].
Differentiation assays were performed in the presence of Epo
(10 U/ml), human transferrin (50 mg/ml, SciPac) and cell size was
monitored with a CASY cell Counter (Roche). Within 48 h the
cells homogeneously reduced their size and started producing
hemoglobin. Globin expression of transgenic mice and cell lines
was followed by flow cytometry, fluorescence microscopy IX-70
(Zeiss) or confocal microscopy (Zeiss) and standard RNA analysis
techniques.
Hanging drop cultures were performed as described [17].
100 mM Hydroxyurea (HU, Sigma), 300 nM 5-Azacytidine
(AZA, Sigma) and 200 mM RB7 (SPECS, Delft, The Netherlands)
were added when indicated.
Azacytidine treatment of transgenic mice
Transgenic and wild type C57BL/6 mice were treated as
described [12]. Blood was resuspended in PBS and analyzed with
a FACSAriaII. Bone marrow was cultured in hanging drop
cultures [17] and analyzed by flow cytometry as mentioned before.
Viral transduction
Knockdown experiments for different target genes were
performed in transgenic fetal liver cell lines and in primary cells
with concentrated virus. The shRNA plasmids are part of the
TRC1 Mission shRNA library (Sigma). Lenti viruses were
produced using a third generation system [18]. 20 mg of DNA
plasmid from the TRC1 library together with helper plasmids
were co-transfected in 293T cells with Polyethylenimine (PEI,
Sigma) and supernatant was harvested during the next three
consecutive days followed by filtration and centrifugation at 20 K
rpm for 2 hours at 4uC.
Fetal liver cells were transduced with virus and grown under
puromycin (1 mg/ml) selection for a maximum of one week.
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Western blots
Nuclear or whole cell protein extracts were semi-dry blotted to
PVDF (Millipore) membrane and staining performed according to
standard protocols. The ECL kit (Amersham Biosciences) was used
to develop the membrane.
Primary antibodies used were: cMyb (SantaCruz-516), Bcl11a
(Santa Cruz-56013) Hdac3 (AbCam-32369), Fop (KT64; Absea
Biotechnology), Actin (sc-1616; Santa Cruz Biotechnology) and
Nucleophosmin (Abcam-10530) all in 1:2000 dilution. Anti-mouse
IgG coupled to HRP (1:20000) was used for detection.
Statistical analysis
2-tailed T-test was performed when indicated.
Results
Modification of the human b-globin locus and
generation of transgenic mouse lines carrying the dual
reporter
In order to generate a mouse model where the expression of
human globin genes can be followed by fluorescence, we
introduced the GFP cDNA (EGFP-N1, Clontech) in the first
ATG codon of the HBG1 gene (PAC2 vector) and the DsRed
cDNA (DsRed2, Clontech) in the first ATG codon of the HBB
gene (PAC2 vector), both ending by a stop codon (Figure 1A)
without replacing the endogenous transcripts. The same strategy
was followed to generate the second transgenic line, which has the
GFP fused to the erythroid-specific membrane protein Glyco-
phorin A (GPA) as the c-globin reporter (Figure 1A and B). GPA
was chosen in order to express the GFP protein in the erythroid
cell membrane rather than in the cytoplasm, to reduce possible
fluorescence quenching due to high hemoglobin concentrations in
the cytoplasm (Figure 1C). Since GPA-GFP has to be efficiently
transported to the plasma membrane we tested the functionality of
the fusion protein GPA-GFP by transducing a fetal liver cell line
with a GPA-GFP lentivirus. Expression of GFP in the plasma
membrane was confirmed by confocal microscopy (Figure 1C).
The modified human b-globin locus devoid of any sequences of
the PAC2 vector (SceI digest, Figure 1A) was injected in fertilized
C57BL/6 oocytes to generate transgenic mice. Extensive mapping
of the modified locus was performed after each modification in
bacteria and on tail DNA of founders by Southern blotting (data
not shown and Figure 1D) using as probes two cosmids spanning
the b-globin locus (,70 Kb), cosLCRe and cosccdb, as described
[2]. Two transgenic lines cGFP/bDsRed were obtained with two
and one copy of the transgene respectively. Three founders of the
cGPA-GFP/bDsRed construct were obtained, one of which
transmitted the transgene to the next generation and was found
to carry two copies of the transgene. Mouse globin gene expression
during development was examined in transgenic embryos of both
lines carrying two copies by S1 nuclease protection assays, and was
found to be normal in terms of globin gene expression at the
respective developmental stage (data not shown and Figure 1E).
As revealed by flow cytometry analysis (Figure 1C and data not
shown), the difference between the two constructs (cGFP/bDsRed
and cGPA-GFP/bDsRed, both carrying two copies) was small
with respect to GFP detection in 12.5dpc blood cells. However,
expressing the GFP protein on the cell surface, i.e. away from the
cytoplasmic hemoglobin-rich environment of the erythrocyte,
facilitates the detection of fluorescence signals on erythroid cells
upon differentiation. For this reason, we chose to perform the
developmental analysis of reporter expression with the cGPA-
GFP/bDsRed transgenic mice.
Human HBG1/HBB-globin gene reporter expression in
cGPA-GFP/bDsRed transgenic mice during development
The flow cytometry analysis that was carried out in embryonic
blood and fetal liver from embryos at different developmental
stages was in concordance with previous studies of human globin
gene expression in the mouse [2]. We could detect GFP expression
in practically all circulating erythroid cells at 11.5dpc and 12.5dpc,
after which the percentage of GFP-positive cells started to decline
(Figure 2A and B). At 14.5dpc we could still detect GFP expression
in a subpopulation of cells although their percentage was low
(8.62%). These cells were side scatter high (SSChigh) indicating that
they were primitive cells still in the circulation (Figure 2A and B)
[9]. Furthermore, qPCR analysis of GFP transcript in WT and
cGPA-GFP/bDsRed fetal liver cells at 11.5dpc and 14.5dpc
revealed GFP transcripts present in transgenic fetal liver cells at
11.5dpc (derived from primitive circulating cells), but not at 14.5dpc
(Figure 2C).
A small fraction of fetal liver cells (Figure 3A, arrowhead) is
positive for DsRed at 11.5dpc and 12.5dpc. At 14.5dpc, when
expression of b-globin gene is high, it is extremely difficult to
detect DsRed positive cells. When analyzing fetal blood for the
expression of DsRed, we found no expression at 11.5dpc and
12.5dpc, as expected; however, as in the fetal liver, we could not
detect DsRed in 14.5dpc blood (data not shown). Since the
absorbance spectrum of hemoglobin [19–21] overlaps with the
emission spectrum of DsRed (550 nm–700 nm), it seems likely that
fully hemoglobinized cells would quench (cytoplasmic) DsRed
emission in blood definitive cells and in the fetal liver context [22].
Indeed, qPCR analysis of DsRed transcript in WT and cGPA-
GFP/bDsRed fetal liver cells in mice revealed DsRed transcripts
present at 14.5dpc, but not at 11.5dpc (Figure 3B). Due to the fact
that 14.5dpc fetal livers contain a relatively high proportion of
mature, fully hemoglobinized erythroid cells, and in order to see
whether we could detect DsRed expression in a more synchronous
differentiating population outside the fetal liver context, we
differentiated fetal liver cells in vitro in a hanging drop culture
system [17]. As expected, we were able to detect DsRed
expression, but not GFP expression, after two days of differenti-
ation of 14.5dpc fetal liver cells in hanging drop cultures (i.e. b-
globin is being expressed) (Figure 3C). Therefore, the combination
of dual reporter fetal liver cells and the hanging drop culture
system provides a tool for screening chemical, antibody or shRNA
libraries in a low-cost manner.
In vivo treatment of transgenic mice with 5-Azacytidine
Rupon and coworkers have described that stress erythropoiesis
induction in combination with 5-azacytidine treatment in b-globin
YAC mice resulted in reactivation of c-globin, as measured by
mRNA expression in circulating reticulocytes [12]. In order to
assess whether we could detect those c-globin expressing cells
directly in the adult blood by flow cytometry, cGPA-GFP/
bDsRed as well as WT mice were treated with phenylhydrazine
(PHZ) and 5-azacytidine (AZA) according to this procedure [12].
In this manner we wished to validate the dual reporter mice for in
vivo studies with more direct clinical relevance. The treatment
consisted of PHZ intraperitoneal (i.p.) injections the first two days
followed by AZA i.p. injections the next five consecutive days.
Control WT and transgenic mice were either injected with PHZ
followed by PBS instead of AZA (data not shown) or PBS only
throughout the seven days of treatment (control mice).
At the end of treatment, blood was analyzed by flow cytometry
and bone marrow cells were differentiated in vitro in hanging drop
(HD) cultures [17] prior to flow cytometry analysis.
Reporter Mouse Model of the Human b-Globin Locus
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Figure 1. Modification of the human b-globin locus and generation of transgenic dual reporter mouse lines. (A) The human b-globin
locus (SceI flanked) PAC used for the modifications made in the c- and b-globin genes. GFP and DsRed were introduced in the ATG (+1) position of
the transcripts followed by a stop codon (*). (B) Schematic representation of the GPA-GFP construct. The grey numbered stretches of the cartoon (1–
114, 834–1234 bp) represent the glycophorin-A cDNA and the green stretch represents the GFP cDNA (114–834). The bilayer represents the
transmembrane part of the protein, thus the GFP is expressed in the extracellular part of the fusion GPA-GFP protein. (C) Representative picture of
K562 cells transfected with the cGFP/bDsRed modified human b-globin locus to check expression of c-globin and flow cytometry analysis of GFP
expression in 12.5dpc embryonic blood of cGFP/bDsRed transgenic embryos (left). Representative picture of fetal liver cells transduced with the
cGPA-GFP construct to check expression of GFP protein in the plasma membrane and flow cytometry analysis of GFP expression in 12.5dpc
embryonic blood of cGPA-GFP/bDsRed transgenic embryos (right). Mean fluorescence intensity (MFI) ratio is indicated in both graphs. (D) Southern
blot of both mouse transgenic lines (cGFP/bDsRed and cGPA-GFP/bDsRed). Tail genomic DNA was digested with SacI restriction enzyme and
hybridized with cosLCRe (left) and cosccdb (right), as previously described [2]. Lane 1: cGPA-GFP/bDsRed tail DNA, Lanes 2, 3: mouse line PAC8
carrying the human b-globin locus and Lane 4: cGFP/bDsRed tail DNA. Symbolx indicates end fragments, c HGG1 3.6 Kb SacI fragment,cc HGG1-
GFP 4.3 Kb SacI fragment, ccc HGG1-GPA-GFP 4.9 Kb SacI fragment,X b-DsRed modification (16.4 to 17 Kb fragment). (E) S1 nuclease protection
analysis of mouse globin expression of WT and transgenic mice at different developmental stages as indicated.
doi:10.1371/journal.pone.0051272.g001
Reporter Mouse Model of the Human b-Globin Locus
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As shown in Figure 4A, treated transgenic mice displayed an
increased number of GFP+ cells as opposed to mock-treated
transgenic mice, indicating that stress erythropoiesis caused by
induced hemolytic anemia and followed by AZA administration
reactivates the production of human c-globin in the mouse
[12,23].
The low percentage of F-cells [24] expected in blood during a
stress response correlates with the numbers of GFP+ cells detected
by flow cytometry. Furthermore, we detected GFP+ cells co-
expressing DsRed (Figure S1A, Table S1).
These results were further verified by culturing bone marrow
cells of treated mice in hanging drops (HD) where terminal
differentiation occurs more synchronously and globin reporter
expression detection is favored, as demonstrated in Figure 3C. At
Day 2 of HD culture, the cells were analyzed by flow cytometry.
This revealed that the number of GFP+ cells is much higher in
bone marrow cells derived from treated cGPA-GFP/bDsRed
mice when compared to those derived from mock treated mice
(Figure 4B). The pattern was similar to that obtained directly from
peripheral blood (Figure S1B and Table S2, cells co-expressing
GFP and DsRed). Interestingly, compared to the measurements of
whole blood, we required 10- to 50-fold fewer cells for flow
cytometry analysis of the HD cultures in order to gate sufficient
GFP+ events for statistical analysis, and the background or auto-
fluorescence was reduced. Most importantly, the HD assay can be
used in high-throughput assays, requiring minimum amounts of
material of both cells and testing agents.
Transgenic fetal liver cell lines and in vitro assays
With the purpose of obtaining stable cell lines for molecular
studies, we generated mouse fetal liver cell lines from transgenic
embryos (11.5dpc–14.5dpc) and control (WT) cell lines from
Figure 2. Analysis of GFP (c-globin) expression during development. (A) Histogram overlay of embryonic blood from transgenic and WT
embryos in the GFP axis. The percentages of positive GFP cells and primitive cells for each developmental stage are included in the table underneath
(SSC: side scatter). Differences in the MFI of WT cells amongst the three histograms shown are due to the developmental stage and the gated cells
plotted (i.e. SSChigh in the third histogram). (B) Dot plot depicting embryonic blood of representative cGPA-GFP/bDsRed transgenic mice at 14.5dpc in
which the GFP+ population is depicted as green dots against the Forward (FSC) and Side Scatter (SSC). GFP+ cells (8.6262.68%) are SSChigh, i.e.
primitive cells. (C) qPCR analysis of GFP expression in WT and transgenic fetal liver cells at 11.5dpc and 14.5dpc. RFE is relative fold enrichment.
Average and standard deviation derived from three mice per group is depicted. T-test was performed to calculate the p values.
doi:10.1371/journal.pone.0051272.g002
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littermates after crossing them to homozygosity to the p53
knockout background as described [15,16].
The cells can be kept in culture continuously with serum-free
media supplemented with erythropoietin (Epo), stem cell factor
(SCF) and dexamethasone (Dex). They divide as normal primary
mouse fetal liver cells and can be easily driven to differentiation
upon replacement of the Epo, SCF and Dex by transferrin and a
higher dose of Epo. Most importantly, the differentiation of the
Figure 3. Analysis of DsRed (b-globin) expression during development. (A) Flow cytometry analysis of fetal liver of cGPA-GFP/bDsRed
transgenic mice during development. Arrowhead at 11.5dpc and 12.5dpc indicates the DsRed positive population. Representative data are depicted.
(B) qPCR analysis of DsRed expression in WT and transgenic fetal liver cells at 11.5dpc and 14.5dpc. RFE is relative fold enrichment. Average and
standard deviation derived from three mice per group is depicted. T-test was performed to calculate the p values. (C) Histogram overlays of DsRed
and GFP expression in 14.5dpc fetal liver cells cultured for 2 days in hanging drops. DsRed expression is detected in transgenic cells differentiated in
vitro when compared to WT while GFP is not. Representative data are depicted.
doi:10.1371/journal.pone.0051272.g003
Reporter Mouse Model of the Human b-Globin Locus
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cells is homogeneous as reflected by size reduction towards
terminal differentiation and production of adult mouse globins
(bmaj, data not shown; [15]). Accordingly, cell lines generated
from the transgenic mouse lines reduced their size (Figure 5A) and
expressed the DsRed protein upon differentiation (Figure 5B and
C), which confirms proper protein production of the inserted
DsRed cDNA in the b-globin locus.
Flow cytometry analysis of specific erythroid cell membrane
markers confirmed the early erythroid progenitor stage of the cells
in culture (CD117+ CD71low). Upon differentiation, cKit (CD117)
was downregulated and transferrin receptor (CD71) expression
was upregulated (Figure 5A), confirming their capability to
undergo normal erythroid differentiation.
We have used the fetal liver cells (primary cells and the
established cell lines) from both transgenic lines in several assays,
in order to assess their response upon treatment in culture and
most importantly their sensitivity to such assays.
We determined the effects of hydroxyurea (HU), AZA or RB7
(short chain fatty acid, SCFA) treatment [10,12,25–27] on c-
globin reactivation (Figure S2). To our surprise, most of the
conditions induced morphological changes in erythroid cells,
which resulted in auto-fluorescence of WT treated cultures. This
auto-fluorescence interfered with GFP detection (Figure S2A).
Therefore we proceeded to analyze GFP transcript induction by
qPCR, and normalized the relative fold enrichment by setting
respective controls to 1. In agreement with previous work
[10,12,25–27] all treatments induced GFP expression, i.e. c-globin
reactivation, and AZA was the most potent activator (Figure S2B).
We then tested several shRNA clones for specific downregula-
tion of potential target genes implicated in the regulation of c-
globin gene expression. We have tried several genes, some of
which are presented in Figure 6. Knockdown of cMyb [28],
Bcl11a [29], Hdac3 [26] and Friend of Prmt1 (Fop) [30] resulted
in low, moderate or high induction of GFP expression (Figure 6A).
Knockdown efficiencies were confirmed by Western blot analysis
(Figure 6B).
cMyb is known to act as an inhibitor of terminal erythroid
differentiation [31]. Knockdown of cMyb resulted in GFP (c-
globin) induction (although at low levels) but also DsRed (b-globin)
because the cells underwent differentiation as a result of reduced
protein levels of cMyb. Conversely, overexpression of cMyb
delayed terminal differentiation in vitro (data not shown), preclud-
ing expression of globins.
Bcl11a knockdown increased GFP expression. However, the
GFP expression was not accompanied by DsRed expression to the
same extent as observed with cMyb knockdown (GFP/DsRed
normalized to controls ratios of Bcl11a and cMyb are 0.9 vs 0.7),
consistent with the notion that Bcl11a is a direct target for c-globin
reactivation [28,29,32].
Hdac3 knockdown resulted in high GFP levels in every
transgenic cell line (Figure 6 and data not shown) and induction
of DsRed protein levels to a lower extent (GFP/DsRed normalized
to controls ratio 1.2).
Of note, DsRed expression in cMyb and Hdac3 knockdown
experiments is confined to different populations of cells when
comparing the forward scatter contour plots. In the case of the
cMyb knockdown cells, a DsRed-positive population emerges in
the low Forward Scatter (FSC) area, a clear indication of cell
differentiation. Distinctly, the DsRed positive cells in the Hdac3
knockdown are found in the mid-high FSC area, as occurs with
GFP positive cells. This indicates that Hdac3 knockdown results in
expression of globins independently of cell differentiation and due
to epigenetic changes in the chromatin. This result is in
concordance with the co-expression of GFP and DsRed in
circulating erythroid cells of PHZ+AZA treated mice (Figure 4
and Figure S1), as AZA also acts modifying the epigenetic
signature of chromatin by inhibiting methyltransferases [23,33]
and might induce downregulation of Hdac1 and Hdac3 [34].
Finally, when Friend of Prmt1 (Fop) expression was inhibited we
observed an increase in the GFP levels represented by almost all
cells (Figure 6A) (GFP/DsRed normalized to controls ratio 1.8).
This is in accordance with recently published data [30].
The performed knockdown experiments demonstrate that the
cell lines derived from primary cells of transgenic mice respond in
agreement with the literature upon manipulation of the expression
levels of transcription factors, which are known to influence the
erythroid differentiation status in addition to the globin gene
expression. The generated cell lines resemble definitive erythro-
poietic progenitors, i.e. they are at the developmental stage
expressing b-globin. Therefore, these cells are a useful tool to study
the activation of globin genes and in particular the reactivation of
c-globin (GFP).
Discussion
In order to understand how globin genes are expressed during
each developmental stage several in vivo and in vitro models have
been generated [2,9–13,25,26,35,36]. The complexity of human
globin switching from the fetal c-globin to the adult b-globin has
raised multiple questions that need to be addressed by accurate
and flexible models allowing application of high-throughput
techniques. Erythroid cell lines such as MEL and K562 have
been extensively used and genetically manipulated to provide
evidence of globin gene regulation in mouse and human in vitro
models [10,11]. The generation of transgenic mice bearing the
human b-globin locus allowed dissection of the developmental
pattern of globin gene expression and regulation, displaying many
similarities but also differences in globin gene regulation between
mouse and human [2,29]. The use of reporter assays to measure
the activity of specific promoters under certain conditions that
Figure 4. In vivo treatment of transgenic mice with 5-
Azacytidine. (A) Graph representing absolute numbers of GFP+
cells/106 events measured gated in blood of cGPA-GFP/bDsRed mice
treated (PHZ+AZA, red dots) or mock treated (PBS, white dots). (B)
Graph representing absolute numbers of GFP+ cells/105 events
measured after 2 days of bone marrow hanging drop culture (BM HD
D2) derived from cGPA-GFP/bDsRed mice treated (PHZ+AZA, orange
dots) or mock treated (PBS, white dots). A logarithmic scale is used to
better visualize the distribution of values found (each dot represents a
mouse). The average per group is depicted as a black line. P values were
calculated from the Log transformed data with a T-test.
doi:10.1371/journal.pone.0051272.g004
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mimic developmental programs of specific cell types is a classical
strategy to study transcriptional regulation [37].
Previously, several constructs using fluorescent reporters have
been used in the context of a mini-locus construct in mouse
(GM979, MEL) [8,38] and human cell lines (K562) [11,39] by
standard transfection techniques. The main disadvantages of these
studies lie in the position effect variegation of the transgene and
the integrity of the constructs after the transfection procedure
when the whole b-globin locus is used. Another major point is the
selective use of promoter regions and hypersensitive sites of the
LCR for the generation of reporter constructs that, considering the
complex regulation of globin genes, can be suboptimal. A recent
example is provided by the Bcl11a protein, which does not appear
to bind the c-globin promoters but has a major effect on human c-
globin expression when knocked down in human proerythroblasts
[32] and in Bcl11a knockout mice [29]. Recently, cell lines
containing the complete b-globin locus have been generated [10].
However, the copy number of the transgene is not defined in the
latter publication and the use of chemical compounds is not tested
in WT cells for auto-fluorescence, crucial parameters according to
our studies. Furthermore, whilst such erythroleukemic cell lines
represent many aspects of erythropoiesis as it occurs in vivo, the
exogenous transgene is not taken through the epigenetic repro-
gramming occurring during development of the definitive
erythroid system.
This drawback has been overcome by the transgenic mouse
lines carrying the modified b-globin locus presented in this study.
The mice were analyzed for integrity of the transgenes and for
developmental regulation of the reporter genes, which contrary to
what has been described by Chan and coworkers, do not replace
the endogenous globin genes. To minimize quenching of
fluorescence due to the highly absorbent hemoglobin environment
of the definitive red cell we used the fusion cGPA-GFP/bDsRed
construct. Expression of GPA-GFP on the erythroid cell outer
membrane provided clues about the limits and sensitivity of the
dual reporter system in vivo and in vitro. Such a strategy has been
used by others, who chose instead the nucleus to locate the GFP
fluorescent protein by fusing it to H2B histone [36]. This way,
Isern and coworkers [36] marked primitive erythroid cells since
they expressed it under the regulatory elements of the human HBE
Figure 5. Characterization of the transgenic dual reporter fetal liver cell lines. (A) Flow cytometry analysis of transgenic fetal liver cell lines
before and after differentiation. Histograms against forward scatter and erythroid surface markers CD117 (cKit) and CD71 (transferrin receptor) are
depicted. (B) Flow cytometry analysis of transgenic fetal liver cell lines before and after differentiation. Histograms against DsRed and GFP are
depicted. (C) Representative pictures taken during erythroid differentiation of transgenic fetal liver cell lines. Arrows indicate spontaneously
differentiating cells expressing DsRed protein (left) and differentiated cells with much smaller size that are not as bright as the bigger ones, as a
consequence of the continuous production of endogenous hemoglobin and subsequent quenching of cytoplasmic DsRed fluorescent signal (right).
doi:10.1371/journal.pone.0051272.g005
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promoter. In our model system, and as shown by others, we could
assign c-globin expression to primitive erythroid cells based on
flow cytometry analysis of 11.5dpc–14.5dpc fetal blood [29].
The problem of fluorescence quenching in the red cells has been
noticed previously [21,35,37,40] and is difficult to overcome
especially when moderate levels of expression are achieved, i.e.
with low copy number of the transgene and even more important,
in the case of c-globin reactivation. Our study emphasizes
particularly on both issues by comparing the two mouse lines
(cGFP/bDsRed versus cGPA-GFP/bDsRed)keeping the copies of
the transgene at minimum, one or two copies.
We noticed an additional problem when agents such as 5-
azacytidine (AZA), hydroxyurea (HU) or RB7 were used and also
with other Hdac inhibitors (data not shown). These agents
changed the morphology of the cells dramatically and exerted
significant levels of auto-fluorescence in WT cells. This is a
limitation that has to be taken in consideration when such
experiments are performed. Therefore, despite the GPA-GFP
Figure 6. Knockdown assays in transgenic dual reporter fetal liver cell lines. (A) Flow cytometry analysis of the knockdown of cMyb, Bcl11a,
Hdac3 and Fop in the cGFP/bDsRed cell line. The same vector with a non-specific shRNA sequence was used as a control. Percentages of cells positive
for GFP (upper panel) and DsRed (lower panel) are shown. Contour plots show gated live cells. (B) Western blots of the knockdown experiments in
protein extracts of transduced cells. Equal numbers of cells are loaded on each lane. w, empty vector control extracts; KD, knockdown extracts.
doi:10.1371/journal.pone.0051272.g006
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protein placed in the plasma membrane when expressed in vivo in
embryonic blood improved the detection of fluorescence signals,
caution should be taken when using agents that can induce auto-
fluorescence in the cells under study. Therefore, a WT cell line
should be always taken along as a negative control.
Despite this limitation, the potential use of this system is broad
and it has the unique advantage that it allows sorting of GFP-
positive (c-globin) cells for further analysis. First, we show by
culturing fetal liver and bone marrow in hanging drops (HD) [17],
which go through terminal differentiation in a more synchronous
manner that globin reporter expression detection is favored as
compared to primary material, suggesting that the HD cultures
can be used in high-throughput assays, requiring minimum
amounts of material of both cells and testing agents and overcome
the noise caused by fully hemoglobinized cells in primary tissues.
Screens of libraries of shRNA clones or synthetic antibodies are
unbiased approaches that can be applied to the dual reporter b-
globin locus cell lines. Thus, these lines provide a tool for
identification of changes at the molecular level in a population of
cells or at single cell level using high-throughput assays. When
potential candidate compounds or drugs proven to reactivate c-
globin in vitro are selected, translational studies could be performed
with the mouse lines. As an example, we demonstrated detection
of GFP+ cells upon stress erythropoiesis induction followed by
AZA treatment. Of note, we observed that the GFP+ cells co-
expressed DsRed, an observation that would be missed when
analyzing RNA isolated from the pool of circulating reticulocytes.
In concordance with this result, we also found co-expression of
DsRed and GFP in vitro when knocking down Hdac3, which is not
surprising since AZA also acts modifying the epigenetic signature
of chromatin by inhibiting methyltransferases [23,33] and might
induce downregulation of Hdac1 and Hdac3 [34].
In our in vitro cultures of transgenic fetal liver cells in the
presence of AZA or HU, we could detect by qPCR upregulation of
DsRed transcript, although not at the same extent as GFP
transcript (data not shown and Figure S2B). Unfortunately, due to
the auto-fluorescence induced in the cells, it was not possible to
assess by flow cytometry whether the cells expressing GFP do co-
express DsRed. This limitation could be partly overcome by
choosing new developed fluorescent proteins (e.g. mNeptune) with
emission wavelengths in the far red, highly stable and photo-
bleaching resistant. This would reduce auto-fluorescence and
quenching due to hemoglobin in these spectra or at least minimize
it at levels that do not compromise the results in high-throughput
assays [22]. However, these ‘‘improved’’ fluorescent proteins have
to be tested in vivo for their functionality. Our decision on choosing
the DsRed2 protein for its emission wavelength at 582 nm was
borderline as we observed when using chemical compounds with
unexpected absorbing characteristics or when erythroid cells
matured and enucleated. Structural studies for the development
of brighter proteins in combination with physical separation of
interacting molecules that quench fluorescent signals, as we intend
here by fusing the GFP protein with the membrane GPA, establish
the basis for the future generation of reporter mouse models.
It is important to mention that both in vitro and in vivo assays with
our reporter system have explored for the first time the possibility
of imaging the expression of globin genes upon minimum
manipulation of their genomic context. This is crucial in order
to avoid artifacts and overrating results. Here, we demonstrate that
the efforts for the generation of an optimal reporter system have to
develop further in order to reach maximum sensitivity. In the
meantime, our reporter mice and cell lines provide the necessary
tools for performing reporter assays regarding globin gene
expression as we show by a series of different experiments.
Concluding remarks
We have generated a dual reporter human b-globin locus
mouse model in order to trace the expression of the two b-like
globin genes involved in the fetal to adult switch, i.e. c- and b-
globin genes, while within their intact genomic context. We have
generated from these mouse lines immortalized erythroid trans-
genic fetal liver cell lines, which allow in vitro studies and it is
possible to monitor globin gene expression at the proerythroblast
stage or during differentiation. Such a reporter cell line represents
a physiological analogue of an erythroid progenitor in terms of
proper transcriptional regulation, indispensable for developmental
studies of globin expression and unbiased high-throughput screens.
Such experiments are limited when agents used in the culture alter
cell morphology and/or induce auto-fluorescence, therefore we
propose to conduct them with WT cells as negative control. More
importantly, when identifying potential candidates of c-globin
reactivation, the mouse models generated can be used for in vivo
experiments, where GFP+ cells can be traced directly in an
unbiased manner from circulating erythroid cells or from bone
marrow hanging drop cultures, highlighting its potential applied
and clinical relevance. A compromise has to be taken when
generating reporter mouse models for transcription regulation
studies regarding intact regulatory sequences and low copy
number of the transgene as well as expression levels and structural
properties of the fluorescent protein.
Supporting Information
Figure S1 In vivo treatment of transgenic mice with 5-
Azacytidine. (A) Flow cytometry analysis of PHZ+AZA admin-
istration in transgenic mice (cGPA-GFP/bDsRed). The upper two
contour plots show background levels of fluorescence in peripheral
blood upon PBS administration. The lower panel shows the
response of WT and cGPA-GFP/bDsRed mice upon PHZ and
AZA administration. (B) Bone marrow hanging drop culture of the
treated mice, presented in the same order as above (A).
(TIF)
Figure S2 reatment of transgenic dual reporter fetal
liver cell lines with chemical compounds. (A) Flow
cytometry analysis of WT and transgenic fetal liver cell lines
treated or untreated with HU, AZA or RB7. Histogram overlays
against GFP are depicted. (B) qPCR analysis of GFP expression in
WT and transgenic fetal liver cell lines treated or untreated with
HU, AZA or RB7. RFE is relative fold enrichment. Average and
standard deviation from 3 independent experiments are depicted
after normalization of the untreated or DMSO controls. T-test was
performed to calculate the p values.
(TIF)
Table S1 Absolute cell numbers from blood of
PHZ+AZA/PBS treated mice. Blood of treated (PHZ +
AZA) or mock treated (PBS) mice was analyzed by flow cytometry
and cells positive for DsRed, GFP and DsRed+GFP were counted.
(TIF)
Table S2 Absolute cell numbers from bone marrow
hanging drops of PHZ+AZA/PBS treated mice. Bone
marrow cells from treated (PHZ + AZA) or mock treated (PBS)
mice were differentiated in hanging drops (HD) for two days and
analyzed by flow cytometry. Cells positive for DsRed, GFP and
DsRed+GFP were counted.
(TIF)
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